Applications of proteomics to cell biology and biomedical research require further developments of mass spectrometry (MS) technology to overcome long-standing limitations in speed, sensitivity and ...
Robust, Unbiased and Affordable 4D-Proteomics™ for Highest-Specificity Protein IDs & Quant Enables High-Fidelity Large-Scale Plasma Proteomics Typical Sequence Coverage >10 Peptides/protein and >100k ...
PORTLAND, Ore.--(BUSINESS WIRE)--At the 20 th US Human Proteome Organization Congress 2024, Bruker Corporation (Nasdaq: BRKR) announced progress in immunopeptidomics, glycoproteomics and other ...
Bruker Corporation BRKR recently announced transformative sensitivity on the 4D-Proteomics timsTOF platform with the launch of the timsTOF Ultra mass spectrometer at the 71st ASMS meeting. The company ...
timsTOF Ultra Further Advances Quantitative Spatial and Single-cell 4D-Proteomics and 4D-Lipidomics™, Immunopeptidomics, PTM and Protein-Protein Interactions Analysis - with Speed and Robustness ...
Emerging proteomics technologies are advancing sensitivity, throughput, and reproducibility, enabling robust biomarker discovery, target identification, and translational research at scale. Global ...
Ion-mobility spectrometry (IMS) separates and characterizes ions in the gas phase based on their mobility within a carrier gas. IMS has recently being coupled with mass spectrometry (MS) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results